Use of Bevacizumab in the Neoadjuvant Setting for Patients with Locally Advanced Rectal Cancer
Use of Bevacizumab in the Neoadjuvant Setting for Patients with Locally Advanced Rectal Cancer
Slides from a presentation at ASCO 2010 and transcribed comments from recent interviews with Axel Grothey, MD (7/9/10) and Alan P Venook, MD (6/16/10)
Schrag D et al. Neoadjuvant FOLFOX with bevacizumab but without pelvic radiation for locally advanced rectal cancer. Proc ASCO 2010;Abstract 3511. |
||||||||